Paper2327770
Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis.
Hughes WT and 4 others. Antimicrob Agents Chemother, 1990. Cited by 120 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. Papers, record 2327770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2327770
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Infective Agents | Major topic |
| Naphthoquinones | Major topic |
| Pneumonia, Pneumocystis | Major topic |
| Animals | |
| Atovaquone | |
| Dexamethasone | |
| Lung | |
| Male | |
| Rats | |
| Rats, Inbred Strains | |
| Tetracyclines | |
| Trimethoprim, Sulfamethoxazole Drug Combination |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6037033 | Naphthoquinone antimalarials. XXIX. 2-hydroxy-3-(omega-cyclohexylalkyl)-1,4-naphthoquinones. | J Med Chem | 1967 | https://conductscience.org/library/papers/6037033 | PubMed |
| 2 | 4365115 | Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4365115 | PubMed |
| 3 | 934316 | Chemotherapy of Theileria parva infection. | Nature | 1976 | https://conductscience.org/library/papers/934316 | PubMed |
| 4 | 412099 | Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. | N Engl J Med | 1977 | https://conductscience.org/library/papers/412099 | PubMed |
| 5 | 205176 | Lipid peroxidation and the generation of free radicals, superoxide anion, and hydrogen peroxide in beta-lapachone-treated Trypanosoma cruzi epimastigotes. | Arch Biochem Biophys | 1978 | https://conductscience.org/library/papers/205176 | PubMed |
| 6 | 3920634 | Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity. | Parasitology | 1985 | https://conductscience.org/library/papers/3920634 | PubMed |
| 7 | 367298 | In vitro and in vivo evaluation of the toxicity of 1,4-naphthoquinone and 1,2-naphthoquinone derivatives against Trypanosoma cruzi. | Ann Trop Med Parasitol | 1978 | https://conductscience.org/library/papers/367298 | PubMed |
| 8 | 33002 | Superoxide anion production and trypanocidal action of naphthoquinones on Trypanosoma cruzi. | Comp Biochem Physiol C Comp Pharmacol | 1978 | https://conductscience.org/library/papers/33002 | PubMed |
| 9 | 315754 | Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/315754 | PubMed |
| 10 | 6331460 | Potent and selective hydroxynaphthoquinone inhibitors of mitochondrial electron transport in Eimeria tenella (Apicomplexa: Coccidia). | Biochem Pharmacol | 1984 | https://conductscience.org/library/papers/6331460 | PubMed |
| 11 | 702049 | An approach to the development of new drugs for African trypanosomiasis. | J Exp Med | 1978 | https://conductscience.org/library/papers/702049 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31265248 | Design and Application of a High-Throughput, High-Content Screening System for Natural Product Inhibitors of the Human Parasite Trichomonas vaginalis. | ACS Infect Dis | 2019 | https://conductscience.org/library/papers/31265248 | PubMed |
| 23758163 | How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria-targeted drugs. | Br J Pharmacol | 2013 | https://conductscience.org/library/papers/23758163 | PubMed |
| 17383607 | Parameters determining the relative efficacy of hydroxy-naphthoquinone inhibitors of the cytochrome bc1 complex. | Biochim Biophys Acta | 2007 | https://conductscience.org/library/papers/17383607 | PubMed |
| 11959541 | Antiparasitic agent atovaquone. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11959541 | PubMed |
| 10681344 | Effects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. carinii. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10681344 | PubMed |
| 10602716 | Effects of atovaquone and diospyrin-based drugs on ubiquinone biosynthesis in Pneumocystis carinii organisms. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10602716 | PubMed |
| 10348748 | A mechanism for the synergistic antimalarial action of atovaquone and proguanil. | Antimicrob Agents Chemother | 1999 | https://conductscience.org/library/papers/10348748 | PubMed |
| 9624466 | Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials Group. | Antimicrob Agents Chemother | 1998 | https://conductscience.org/library/papers/9624466 | PubMed |
| 9457427 | The lipids of Pneumocystis carinii. | Clin Microbiol Rev | 1998 | https://conductscience.org/library/papers/9457427 | PubMed |
| 8980779 | Efficacy of lasalocid against murine Pneumocystis carinii pneumonitis. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/8980779 | PubMed |
| 8851575 | Activity of oral atovaquone alone and in combination with antimony in experimental visceral leishmaniasis. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8851575 | PubMed |
| 8851570 | Single-dose and steady-state pharmacokinetics of a novel microfluidized suspension of atovaquone in human immunodeficiency virus-seropositive patients. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8851570 | PubMed |
| 8849260 | Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8849260 | PubMed |
| 8619570 | Antipneumocystis activity of 17C91, a prodrug of atovaquone. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/8619570 | PubMed |
| 8556494 | Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes. | Clin Diagn Lab Immunol | 1994 | https://conductscience.org/library/papers/8556494 | PubMed |
| 8504623 | Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia. | Clin Pharmacokinet | 1993 | https://conductscience.org/library/papers/8504623 | PubMed |
| 8363369 | Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8363369 | PubMed |
| 8285620 | In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8285620 | PubMed |
| 8148213 | Examination of some factors responsible for a food-induced increase in absorption of atovaquone. | Br J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/8148213 | PubMed |
| 8067749 | Effects of pentamidine isethionate on Saccharomyces cerevisiae. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8067749 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2327770
GET https://conductscience.org/api/papers/v1/2327770/cited_by?page=2